各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。
微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。
《广州医药》编辑部
目的 观察等离子消融髓核成形术联合神经阻滞治疗椎间盘源性腰痛的临床疗效。方法 将183例椎间盘源性腰痛患者随机分为对照组91例、治疗组92例,分别予综合疗法联合神经阻滞治疗、等离子消融髓核成形术联合神经阻滞治疗,观察两组患者治疗前后目测类比疼痛(Visual Analog Scale VAS)评分、改良Stauffer-Coventry评定系统术后日常活动及满意率等指标。结果 治疗组VAS评分和日常活动及满意率均优于对照组(P<0.05或P<0.001)。结论 等离子消融髓核成形术联合神经阻滞治疗椎间盘源性腰痛疗效显著,值得临床推广。
Objective To observe the effect of percutaneous low-temperature disk plasma ablation (PLDA) and nerve block(NB) on discogenic low back pain. Methods 183 patients were randomly divided into two groups: the control group (n=91) and the treatment group (n=92). Corresponding methods were used to treat everyone, to observe two groups VAS before and after the treatment, daily activities and satisfaction rate of improved Stauffer Coventry evaluation system etc. Results The VAS, daily activities and satisfaction rate of the treat group were distinctly more than that's of the control group (P<0.05 or P<0.001). Conclusion PLDA and NB has the therapeutic effects on the discogenic low back pain patients which is worth promoting.